Brazil Daily Briefing

Hapvida (HAPV3) and Embraer (EMBJ3) diverged sharply in Friday's session — Hapvida collapsed more than 30% on earnings that showed spiralling medical inflation and loss ratios blowing well above guidance. Money Times flagged the pair as emblematic of two Brazil stories: the healthcare sector's structural cost crisis versus the industrials recovery (Embraer cautious but holding). For IBOV allocators, Hapvida's -30%+ at a meaningful index weight is the kind of move that forces rebalancing — watch for forced selling into Monday.

Cosan (CSAN3) announced a R$2.6 billion cisão (spinoff/restructuring), separating business units in what the company framed as a simplification of its holding structure. Cosan is one of Brazil's most complex conglomerates — sugar, ethanol, gas distribution (Comgás), rail (Rumo), mining (Moove) all under one roof. The structural separation could unlock value for individual unit shareholders but near-term creates overhang. This is the corporate action trade to watch in Brazil over the next 30 days.

Money Times reported Brazilian banks are restricting credit access for low-income borrowers and demanding higher collateral — a direct transmission of 10.75% Selic into the consumer economy. This matters for Nu's thesis: Nubank has built its business on serving exactly the borrowers traditional banks are now abandoning, but at 10.75% Selic, the credit risk/reward calculus shifts even for fintechs. COPOM's next meeting is the key calendar event — any signal of cuts would ease this dynamic immediately.